Loncar China BioPharma ETF (CHNA)
CHNA Price and Sentiment
CHNA Latest news
Chinese government has generally had some idea of how much risk Evergrande and other highly leveraged real estate companies pose since last year. Equity holders will most likely be wiped out, with holders of bond and wealth management products taking significant haircuts.
The impact of the policy remedy to China's property market excesses is spreading across global markets. But they would bounce hard on any evidence of a mitigation plan from Beijing.
Here is what you should know about investing in these life changing technologies.
Last week was slightly downbeat for Wall Street on talks of a capital gain tax hike with three big U.S. indexes remaining in the red.
The best pharmaceutical ETFs for Q2 2021 are KURE, MJJ, and POTX.
Check these China ETFs that beat the S&P 500 in the past week, which was U.S. equities?
CHNA: You're Missing Out On This Huge Opportunity In Biopharma
Policy easing in the Chinese economy, cooling trade tensions with the United States and Beijing's efforts for more urbanization have boosted these sector ETFs in 2019.